Recruitment of neutrophils during ige-dependent cutaneous late phase reactions in the mouse is mast cell-dependent partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha

Journal of Clinical Investigation

Volumn 87, Issue 2, 1991, Pages 446-453

  Wershil, Barry K ^a,b   Wang, Zhen Sheng ^a   Gordon, John R ^a   Galli, Stephen J ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Anaphylactic degranulation; Inflammation; Local mast cell reconstitution; Mast cell deficient mice; Passive cutaneous anaphylaxis

Indexed keywords

IMMUNOGLOBULIN E;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INFLAMMATION; MAST CELL DEGRANULATION; MOUSE; MUTANT; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SKIN ANAPHYLAXIS;

ANIMAL; DERMATITIS; IMMUNE SERA; IMMUNOGLOBULIN E; LEUKOCYTES; MALE; MAST CELLS; MICE; NEUTROPHILS; SKIN; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR NECROSIS FACTOR;

EID: 0026065788     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI115016     Document Type: Article

References (56)

1. Dolovich, J., F. E. Hargreave, R. Chalmers, K. J. Shier, J. Gauldie, and J. Bienenstock. 1973. Late cutaneous allergic responses in isolated IgE-dependent reaction. J. Allergy Clin. Immunol. 52:38-46.
2. Solley, G. O., G. Gleich, R. Jordan, and A. Schroeter. 1976. The late phase of the immediate wheal and flare skin reaction. Its dependence on IgE antibodies. J. Clin. Invest. 58:408-420.
3. Lemanske, R. F., and M. Kaliner. 1988. Late-phase allergic reactions. In Allergy: Principles and Practice. Vol. 1. E. Middleton, Jr., C. E. Reed, E. F. Ellis, N. F. Adkinson, Jr., and J. W. Yunginger, editors. C. V. Mosby Co., St. Louis, MO. 224-246.
4. Schleimer, R. P., C. C. Fox, R. M. Naclerio, M. Plaut, J. A. Warner, A. Kagey-Sobotka, and L. M. Lichtenstein. 1985. Role of human basophils and mast cells in the pathogenesis of allergic diseases. J. Allergy Clin. Immunol. 76:369-374.
5. Charlesworth, E. N., A. F. Hood, N. A. Soter, A. Kagey-Sobotka, P. S. Norman, and L. M. Lichtenstein. 1989. Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. J. Clin. Invest. 83:1519-1526.
6. Lemanske, R. F., and M. Kaliner. 1981-1982. Mast cell-dependent late phase reactions. Clin. Immunol. Rev. 1:547-580.
7. Wershil, B. K., T. Murakami, and S. J. Galli. 1988. Mast cell-dependent amplification of an immunologically nonspecific inflammatory response. Mast cells are required for the full expression of cutaneous acute inflammation induced by phorbol 12-myristate 13-acetate. J. Immunol. 140:2356-2360.
8. Matsuda, H., K. Kawakita, Y. Kiso, T. Nakano, and Y. Kitamura. 1989. Substance P induces granulocyte infiltration through degranulation of mast cells. J. Immunol. 142:927-931.
9. Yano, H., B. K. Wershil, N. Arizono, and S. J. Galli. 1989. Substance P-induced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell-dependent. J. Clin. Invest. 84:1276-1286.
10. Tannenbaum, S., H. Oertel, W. Henderson, and M. Kaliner. 1980. The biologic activity of mast cell granules. I. Elicitation of inflammatory responses in rat skin. J. Immunol. 125:325-335.
11. Kaliner, M., and R. Lemanske. 1984. Inflammatory responses to mast cell granules. Fed. Proc. 43:2846-2851.
12. Oertel, H., and M. Kaliner. 1981. The biologic activity of mast cell granules. III. Purification of inflammatory factors of anaphylaxis (IF-A) responsible for causing late-phase reactions. J. Immunol. 127:1398-1402.
13. Schwartz, L. B., and K. F. Austen. 1984. Structure and function of the chemical mediators of mast cells. Prog. Allergy. 34:271-321.
14. Galli, S. J., and L. M. Lichtenstein. 1988. The biology of mast cells and basophils. In Allergy: Principles and Practice. Vol. 1. E. Middleton, Jr., C. E. Reed, E. F. Ellis, N. F. Adkinson, Jr., and J. W. Yunginger, editors. C. V. Mosby Co., St. Louis, MO. 106-134.
15. Holgate, S. T., C. Robinson, and M. K. Church. 1988. Mediators of immediate hypersensitivity. In Allergy: Principles and Practice. Vol. 1. E. Middleton, Jr., C. E. Reed, E. F. Ellis, N. F. Adkinson, Jr., and J. W. Yunginger. editors. C. V. Mosby Co., St. Louis, MO, 135-178.
16. Ghiara, P., D. Boraschi, L. Villa, G. Scapigliatti, C. Taddei, and A. Tagliabue. 1985. In vitro generated mast cells express natural cytotoxicity against tumour cells. Immunology. 55:317-324.
17. Okuno, T., Y. Takagaki, D. H. Pluzuik, and J. Y. Djeu. 1986. Natural cytotoxic (NC) cell activity in basophilic cells: release of NC-specific cytotoxic factor by IgE receptor triggering. J. Immunol. 136:4652-4658.
18. Jadus, M. R., G. Schmunk, J. Y. Djeu, and R. Parkman. 1986. Morphology and lytic mechanisms of interleukin 3-dependent natural cytotoxic cells: tumor necrosis factor as a possible mediator. J. Immunol. 137:2774-2783.
19. Young, J. D.-E., C.-C. Liu, G. Butler, Z. A. Cohn, and S. J. Galli. 1987 Identification, purification, and characterization of a mast cell-associated cytolytic factor related to tumor necrosis factor. Proc. Natl. Acad. Sci. USA. 84:9175-9179.
20. Galli, S. J., B. K. Wershil, J. R. Gordon, and T. R. Martin. 1989. Mast cells: immunologically specific effectors and potential sources of multiple cytokines during IgE-dependent responses. CIBA Found. Symp. 147:53-73.
21. Gordon, J. R., and S. J. Galli. 1990. Mast cells as a source of both preformed and immunologically-inducible TNF-α/cachectin. Nature (Lond.). 346:274-276.
22. Burd, P. R., H. W. Rodgers, J. R. Gordon, C. A. Martin, S. Jayaraman, S. D. Wilson, A. M. Dvorak, S. J. Galli, and M. E. Dorf. 1989. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J. Exp. Med. 170:245-247.
23. Ming, W. J., L. Bersani, and A. Mantovani. 1987. Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J. Immunol. 138:1469-1474.
24. Sayers, T. J., T. A. Wiltrout, C. A. Bull, A. C. Denn III, A. M. Pilaro, and B. Lokesh. 1988. Effect of cytokines on polymorphonuclear neutrophil infiltration in the mouse. J. Immunol. 141:1670-1677.
25. Mantovani, A., and E. Dejana. 1989. Cytokines as communication signals between leukocytes and endothelial cells. Immunol. Today. 10:370-375.
26. Dinarello, C. A. 1988. Biology of interleukin 1. FASEB (Fed. Am. Soc. Exp. Biol.) J. 2:108-115.
27. Wolpe, S. D., G. Davatelis, B. Sherry, B. Beutler, D. G. Hesse, H. T. Nguyen, L. L. Moldawer, C. F. Nathan, S. F. Lowry, and A. Cerami. 1988. Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J. Exp. Med. 167:570-581.
28. Wolpe, S. D., and A. Cerami. 1989. Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines. FASEB (Fed. Am. Soc. Exp. Biol.) J. 3:2565-2573.
29. Burd, P. R., B. J. Rollins, S. D. Wilson, P. R. Billings, C. D. Stiles, and M. E. Dorf. 1988. Comparison of fibroblast and T-cell activation genes. Cell Immunol. 115:481-483.
30. Metzger, H., J.-P. Kinet, H. Blank, L. Miller, and C. Ra. 1989. The receptor with high affinity for IgE. CIBA Found. Symp. 147:93-113.
31. Capron, A., M. Capron, C. Grangette, and J. P. Dessaint. 1989. IgE and inflammatory cells. CIBA Found. Symp. 147:153-170.
32. Kikutani, H., A. Yokato, N. Uchibayashi, K. Yukana, T. Tanaka, K. Sugiyama, E. E. L. Barsumian, M. Suemrua, and T. Kishimoto. 1989. Structure and function of Fc€ receptor II (Fc€RII/CD23): a point of contact between the effector phase of allergy and B cell differentiation. CIBA Found. Symp. 147:23-35.
33. Galli, S. J., and I. Hammel. 1984. Unequivocal delayed hypersensitivity in mast cell-deficient and beige mice. Science (Wash. DC). 226:710-713.
34. Mekori, Y. A., J. C. C. Chang, B. K., Wershil, and S. J. Galli. 1987. Studies of the role of mast cells in contact sensitivity responses: passive transfer of the reaction into mast cell-deficient mice locally reconstituted with cultured mast cell; effect of reserpine on transfer of the reaction with DNP-specific cloned T cells. Cell Immunol. 109:39-52.
35. Wershil, B. K., Y. A. Mekori, and S. J. Galli. 1989. The contribution of mast cells to immunological responses with IgE- and/or T cell-mediated components. In Mast Cell and Basophil Differentiation and Function in Health and Disease. S. J. Galli and K. F. Austen, editors. Raven Press. Ltd., New York. 229-246.
36. Dolovich, J., J. Denberg, Y. N. Kwee, T. Belda, J. Blajchman, and F. E. Hargreave. 1983. Does non-immunologic mast cell mediator release/activation elicit a late cutaneous response? Ann. Allergy. 50:241-244.
37. Jacoby, W., P. V. Cammarata, S. Findlay, and S. H. Pincus. 1984. Anaphylaxis in mast cell-deficient mice. J. Invest. Dermatol. 83:302-304.
38. v mice. Int. Arch. Allergy April. Immunol. 80:85-94.
39. Martin, T. R., J. M. Drazen, and S. J. Galli. 1989. Active anaphylaxis is associated with tachycardia in normal but not mast cell (MC)-deficient mice. FASEB (Fed. Am. Soc. Exp. Biol.) J. 3:A790.
40. d genotypes. Exp. Cell. Biol. 55:63-68.
41. v mice and their increase by bone marrow transplantation. Blood. 52:447-452.
42. d mice: their value for the analysis of the roles of mast cells in biological responses in vivo. Am. J. Pathol. 127:191-198.
43. Liu, F.-T., J. W. Bohn, E. L. Ferry, H. Yamamoto, C. A. Molinaro, L. A. Sherman, N. R. Klinman, and D. H. Katz. 1980. Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization. J. Immunol. 124:2728-2737.
44. 125I-Fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin: demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells. J. Immunol. 139:2605-2614.
45. Mekori, Y. A., and S. J. Galli. 1985. Undiminished immunologic tolerance to contact sensitivity in mast cell-deficient mice. J. Immunol. 135:879-885.
46. Dvorak, H. F., M. C. Mihm, Jr., A. M. Dvorak, B. A. Barnes, E. J. Manseau, and S. J. Galli. 1979. Rejection of first set skin allografts in man. The microvasculature is the critical target of the immune response. J. Exp. Med. 150:322-337.
47. v mice. Evidence that cultured mast cells can give rise to both connective tissue-type and mucosal mast cells. J. Exp. Med. 162:1025-1043.
48. Granstein, R. D., R. Margolis, S. B. Mizel, and D. N. Suader. 1986. In vivo inflammatory activity of epidermal cell-derived thymocyte activating factor and recombinant interleukin 1 in the mouse. J. Clin. Invest. 77:1020-1027.
49. Geissler, E. N., M. A. Ryan, and D. E. Housman. 1988. The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell. 55:185-192.
50. Plaut, M., J. H. Pierce, C. J. Watson, J. Hanley-Hyde, R. P. Nordon, and W. E. Paul. 1989. Mast cell lines produce lymphokines in response to cross linkage of Fc€RI or to calcium ionophore. Nature (Lond.). 339:64-67.
51. Klein, L. M., R. M. Lavker, W. L. Matis, and G. F. Murphy. 1989. Degranulation of human mast cells induces an endothelial antigen central to leukocyte adhesion. Proc. Natl. Acad. Sci. USA. 86:8972-8976.
52. Bevilacqua, M. P., S. Stengelin, M. A. Gimbrone, and B. Seed. 1989. Endotheiial leukocyte adhesion molecule I: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science (Wash. DC). 243:1160-1165.
53. Pober, J. S. 1987. Effects of tumour necrosis factor and related cytokines on vascular endothelial cells. CIBA Found. Symp. 131:170-184.
54. Galli, S. J., A. M. Dvorak, and H. F. Dvorak. 1984. Basophils and mast cells: morphologic insights into their biology, secretory patterns, and function. Prog. Allergy. 34:1-141.
55. Galli, S. J. 1990. Biology of disease. New insights into "the riddle of the mast cells": microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab. Invest. 62:5-33.
56. Gordon, J. R., P. R. Burd, and S. J. Galli. 1990. Mast cells are a source of multifunctional cytokines. Immunol. Today. 11:458-464.